StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
43
This year
5
Publishing Date
2024 - 03 - 05
1
2024 - 02 - 27
1
2024 - 02 - 07
1
2024 - 01 - 30
1
2024 - 01 - 26
1
2023 - 12 - 27
1
2023 - 12 - 18
1
2023 - 12 - 05
1
2023 - 11 - 24
1
2023 - 11 - 22
2
2023 - 07 - 03
1
2023 - 04 - 19
1
2023 - 03 - 13
1
2023 - 02 - 02
1
2023 - 01 - 11
1
2023 - 01 - 06
1
2022 - 07 - 20
1
2022 - 07 - 19
2
2022 - 06 - 14
1
2022 - 06 - 06
1
2022 - 06 - 02
1
2022 - 03 - 04
1
2022 - 02 - 18
1
2022 - 02 - 16
1
2022 - 01 - 19
1
2022 - 01 - 03
1
2021 - 12 - 24
1
2021 - 12 - 20
1
2021 - 12 - 16
1
2021 - 11 - 04
1
2021 - 08 - 05
1
2021 - 07 - 29
1
2021 - 07 - 26
1
2021 - 06 - 29
1
2021 - 06 - 28
1
2021 - 05 - 24
1
2021 - 05 - 11
1
2021 - 04 - 09
1
2021 - 04 - 07
1
2021 - 03 - 25
1
2021 - 03 - 08
1
Sector
Communications
1
Consumer services
1
Electronic technology
2
Health technology
21
Industrial services
1
Information
2
Manufacturing
3
N/a
1
Process industries
2
Producer manufacturing
4
Professional, scientific, and technical services
3
Technology services
8
Tags
Acquisition
55
Agreement
48
Alliances
41
Application
43
Award
80
Awards
129
Biotech-bay
39
Brands
71
Business
55
Cancer
77
Care
44
Ceo
37
Ces
37
China
62
Collaboration
85
Companies
56
Conference
136
Designation
52
Disease
36
Drug
66
Energy
97
Europe
52
Events
83
Financial
45
Global
253
Grant
38
Group
64
Growing
32
Growth
219
Health
115
Innovation
1020
International
51
Iot
36
Management
48
Market
331
Medical
55
Meeting
40
N/a
3587
Offering
35
One
35
Partnership
89
Patent
49
Platform
73
Program
50
Report
185
Research
188
Results
116
Services
44
Smart
37
Solution
45
Solutions
128
Study
46
System
59
Technology
304
Test
41
Therapeutics
57
Therapy
84
Treatment
117
Trial
69
Year
35
Entities
3d systems corporation
1
3m company
2
Abbvie inc.
1
Accenture plc
1
Air products and chemicals, inc.
1
Akoya biosciences inc
2
Albemarle corporation
1
Alkermes plc
1
Astrazeneca plc
1
Autodesk, inc.
1
Bt group plc
1
Cf industries holdings, inc.
1
Check point software technologies ltd.
2
Clariant ag
1
Clarivate plc
2
Danaher corporation
1
Dolphin entertainment, inc.
1
Eastman chemical company
1
Eco innovation group, inc.
1
Element solutions inc.
1
Eli lilly and company
10
Enlivex therapeutics ltd.
1
Ericsson
1
Hall of fame resort & entertainment company
1
Icl group ltd.
1
Ies holdings, inc.
1
Incyte corporation
13
Innovative designs inc
2
Intel corporation
1
Johnson & johnson
1
Johnson controls international plc
1
Liquid media group ltd.
1
Luna innovations incorporated
1
Marrone bio innovations, inc.
1
Materialise nv
1
Nanovibronix, inc.
1
Novartis ag
1
Ppg industries, inc.
1
Sana biotechnology inc
2
Sanofi
9
Scienjoy holding corporation
1
Snowflake inc.
1
Ss innovations international, inc.
1
Sumitomo chemical co., ltd.
1
Sumo logic, inc.
1
Ucloudlink group inc.
1
Wearable devices ltd.
1
Wisekey international holding ag
1
Symbols
ABBV
1
ACN
1
ADSK
1
AKYA
2
ALB
1
ALKS
1
APD
1
AZN
1
BTGOF
1
CF
1
CHKP
2
CLVT
2
CLZNF
1
CLZNY
1
DDD
1
DHR
1
DLPN
1
ECOX
1
EMN
1
ENLV
1
ERIC
1
ESI
1
HOFV
1
ICL
1
IESC
1
INCY
13
INTC
1
IVDN
2
JCI
1
JNJ
1
LLY
10
LUNA
1
MBII
1
MMM
2
MTLS
1
NAOV
1
NVS
1
PPG
1
SANA
2
SJ
1
SNOW
1
SNY
9
SNYNF
7
SOMMF
1
SOMMY
1
SSII
1
SUMO
1
UCL
1
WKEY
1
WLDS
1
YVR
1
Exchanges
Nasdaq
38
Nyse
20
Crawled Date
2024 - 03 - 05
1
2024 - 02 - 27
1
2024 - 02 - 07
1
2024 - 01 - 30
1
2024 - 01 - 26
1
2023 - 12 - 27
1
2023 - 12 - 18
1
2023 - 12 - 05
1
2023 - 11 - 24
1
2023 - 11 - 22
2
2023 - 07 - 03
1
2023 - 04 - 19
1
2023 - 03 - 13
1
2023 - 02 - 02
1
2023 - 01 - 11
1
2023 - 01 - 06
1
2022 - 07 - 20
2
2022 - 07 - 19
1
2022 - 06 - 14
1
2022 - 06 - 06
1
2022 - 06 - 02
1
2022 - 03 - 04
1
2022 - 02 - 18
1
2022 - 02 - 16
1
2022 - 01 - 19
1
2022 - 01 - 03
1
2021 - 12 - 24
1
2021 - 12 - 20
1
2021 - 12 - 16
1
2021 - 11 - 04
1
2021 - 08 - 05
1
2021 - 07 - 29
1
2021 - 07 - 26
1
2021 - 06 - 29
1
2021 - 06 - 28
1
2021 - 05 - 24
1
2021 - 05 - 11
1
2021 - 04 - 09
1
2021 - 04 - 07
1
2021 - 03 - 25
1
2021 - 03 - 08
1
Crawled Time
00:00
1
01:00
6
04:00
1
05:00
1
08:00
1
09:00
2
10:00
1
11:00
1
11:11
1
12:00
2
12:15
4
13:00
4
13:15
2
13:30
1
14:00
3
14:30
1
15:00
1
17:00
5
18:00
2
19:00
1
20:00
1
21:00
1
Source
investor.alkermes.com
1
snowflake.net
1
www.biospace.com
7
www.globenewswire.com
11
www.prnewswire.com
23
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
innovation
tags :
Application
save search
AnHeart Therapeutics and Innovent Announce China’s NMPA has Accepted Second New Drug Application for Taletrectinib for First-Line Treatment of ROS1-Positive Lung Cancer
Published:
2024-03-05
(Crawled : 08:00)
- biospace.com/
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-2.4%
|
O:
1.17%
H:
0.0%
C:
0.0%
lung
drug
cancer
treatment
application
therapeutics
In-Vitro Diagnostics Market in Saudi Arabia Set for Significant Expansion by 2030 with Emphasis on Technology and Application Innovations
Published:
2024-02-27
(Crawled : 04:00)
- prnewswire.com
DHR
|
$239.39
-0.4%
0.03%
2.9M
|
Health Technology
|
-4.48%
|
O:
0.21%
H:
1.38%
C:
1.09%
expansion
set
in-vitro
application
technology
diagnostics
market
Innovent's First New Drug Application of Mazdutide for Chronic Weight Management has been Accepted by the NMPA of China
Published:
2024-02-07
(Crawled : 09:00)
- prnewswire.com
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
5.92%
|
O:
0.76%
H:
4.31%
C:
2.11%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-1.42%
|
O:
1.33%
H:
0.0%
C:
0.0%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-10.75%
|
O:
-0.65%
H:
0.57%
C:
-3.21%
first
management
drug
application
china
BT Group Selects Optiva for Next-Generation Application Server Upgrade to Build and Deploy Innovative New Services
Published:
2024-01-30
(Crawled : 13:00)
- globenewswire.com
BTGOF
|
$1.31
12.9%
120K
|
Communications
|
-9.66%
|
O:
0.0%
H:
0.0%
C:
0.0%
services
group
application
SS Innovations Announces Filing of Pre-Submission Application to the Center for Devices and Radiological Health (CDRH) of the United States Food and Drug Administration
Published:
2024-01-26
(Crawled : 13:00)
- globenewswire.com
SSII
|
$5.5
3.7%
1K
|
n/a
|
27.91%
|
O:
0.0%
H:
15.12%
C:
6.98%
drug
health
food
application
World International Patent Organization (WIPO) Application Accepted on Superior Insulation Advancement to Maximize Global Marketing Opportunities for Innovative Designs, Inc.
Published:
2023-12-27
(Crawled : 18:00)
- globenewswire.com
IVDN
4
|
$0.16
73.97%
13K
|
Manufacturing
|
Email alert
Add to watchlist
patent
world
international
global
application
insulation
Wearable Devices Sets New Standard in AR/VR Era with U.S Patent Application for Innovative Touchless Technology
Published:
2023-12-18
(Crawled : 13:00)
- globenewswire.com
WLDS
|
$0.4995
2.82%
2.74%
360K
|
|
45.03%
|
O:
4.48%
H:
1.66%
C:
-4.46%
patent
application
technology
Snowflake’s AWS re:Invent Highlights for Fast-Tracking ML, Gen AI and Application Innovations
Published:
2023-12-05
(Crawled : 21:00)
- snowflake.net
SNOW
|
$148.8
-1.0%
-0.11%
3.8M
|
Technology Services
|
-19.26%
|
O:
0.67%
H:
1.71%
C:
-1.57%
gen
application
China's First NDA for a KRAS G12C Inhibitor: Innovent Announces the National Medical Products Administration of China Has Accepted and Granted Priority Review Designation to the New Drug Application for IBI351
Published:
2023-11-24
(Crawled : 01:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-0.95%
|
O:
0.69%
H:
1.66%
C:
1.66%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-1.21%
|
O:
1.46%
H:
0.0%
C:
0.0%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-0.34%
|
O:
0.34%
H:
0.37%
C:
0.3%
ibi351
drug
granted
review
designation
medical
application
china
AnHeart Therapeutics and Innovent Announce China’s NMPA Has Accepted a New Drug Application for Taletrectinib (ROS1 Inhibitor)
Published:
2023-11-22
(Crawled : 17:00)
- biospace.com/
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-0.98%
|
O:
-0.74%
H:
0.71%
C:
0.71%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-1.55%
|
O:
-0.34%
H:
0.0%
C:
0.0%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-0.02%
|
O:
0.56%
H:
1.06%
C:
-0.24%
drug
application
therapeutics
Innovent and AnHeart Therapeutics Announce the National Medical Products Administration of China Has Accepted the New Drug Application for Taletrectinib (ROS1 Inhibitor)
Published:
2023-11-22
(Crawled : 13:30)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-0.98%
|
O:
-0.74%
H:
0.71%
C:
0.71%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-1.55%
|
O:
-0.34%
H:
0.0%
C:
0.0%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-0.02%
|
O:
0.56%
H:
1.06%
C:
-0.24%
drug
medical
application
therapeutics
china
IASO Bio and Innovent Announce the NMPA Approval of the New Drug Application for Equecabtagene Autoleucel, the World's First Fully-human BCMA CAR-T Therapy, for the Treatment of Relapsed and/or Refractory Multiple Myeloma
Published:
2023-07-03
(Crawled : 00:00)
- prnewswire.com
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-14.21%
|
O:
1.24%
H:
0.0%
C:
0.0%
drug
approval
treatment
application
car-t
Alkermes Announces Application Period for 2023 Alkermes Inspiration Grants® Program to Support Innovative Initiatives Focused on People Affected by Addiction, Serious Mental Illness or Cancer
Published:
2023-04-19
(Crawled : 12:00)
- investor.alkermes.com
ALKS
|
$24.05
1.18%
1.16%
2.3M
|
Health Technology
|
-18.74%
|
O:
-0.21%
H:
0.51%
C:
0.38%
grants
cancer
application
program
GigaOm Recognizes Check Point Software as a Leader in Innovation in its Application and API Security Report
Published:
2023-03-13
(Crawled : 17:00)
- globenewswire.com
CHKP
|
$158.18
0.88%
0.87%
650K
|
Technology Services
|
25.41%
|
O:
-0.17%
H:
0.81%
C:
-0.83%
report
application
security
software
innovation
Frost & Sullivan Recognizes Check Point Software Technologies as a Leader in Innovation and R&D for Cloud Native Application Protection
Published:
2023-02-02
(Crawled : 01:00)
- globenewswire.com
CHKP
|
$158.18
0.88%
0.87%
650K
|
Technology Services
|
21.03%
|
O:
0.36%
H:
0.03%
C:
-0.83%
application
software
innovation
cloud
Innovative Designs Receives Notice of Allowance on Patent Application
Published:
2023-01-11
(Crawled : 19:00)
- globenewswire.com
IVDN
4
|
$0.16
73.97%
13K
|
Manufacturing
|
-35.87%
|
O:
19.84%
H:
0.0%
C:
-11.54%
patent
application
Innovent Announces the National Medical Products Administration in China Has Accepted and Granted Priority Review Designation to the New Drug Application for Parsaclisib (PI3Kδ inhibitor) for the Treatment of Relapsed or Refractory Follicular Lymphoma
Published:
2023-01-06
(Crawled : 05:00)
- prnewswire.com
SNYNF
|
$92.116
-2.18%
2.3K
|
Health Technology
|
-6.77%
|
O:
-0.35%
H:
0.0%
C:
-2.69%
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
108.05%
|
O:
0.3%
H:
1.86%
C:
0.82%
SNY
|
$46.125
0.71%
0.7%
3.7M
|
Health Technology
|
-3.92%
|
O:
0.02%
H:
0.0%
C:
0.0%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-33.61%
|
O:
1.05%
H:
0.2%
C:
-0.16%
treatment
designation
drug
medical
application
granted
review
china
Innovent and Ascentage Pharma Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML
Published:
2022-07-19
(Crawled : 01:00)
- biospace.com/
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
132.07%
|
O:
0.72%
H:
1.02%
C:
0.65%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-33.89%
|
O:
-0.83%
H:
0.0%
C:
0.0%
treatment
designation
pharma
drug
application
granted
review
china
Innovent and Ascentage Pharma Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML
Published:
2022-07-20
(Crawled : 01:00)
- prnewswire.com
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
128.92%
|
O:
0.27%
H:
0.22%
C:
-1.55%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-33.33%
|
O:
2.32%
H:
1.21%
C:
0.99%
treatment
designation
pharma
drug
application
granted
review
china
Ascentage Pharma and Innovent Announce the China NMPA Accepted and Granted Priority Review Designation to a New Drug Application for Olverembatinib for the Treatment of Drug-Resistant CML
Published:
2022-07-19
(Crawled : 17:00)
- prnewswire.com
LLY
|
$750.77
0.54%
-0.04%
3.1M
|
Health Technology
|
132.07%
|
O:
0.72%
H:
1.02%
C:
0.65%
INCY
|
$52.74
-0.9%
-0.91%
2.5M
|
Health Technology
|
-33.89%
|
O:
-0.83%
H:
0.0%
C:
0.0%
treatment
designation
pharma
drug
application
granted
review
china
← Previous
1
2
3
Next →
Gainers vs Losers
56%
44%
Top 10 Gainers
INVO
|
$1.76
131.58%
56.82%
230M
|
Health Technology
SINT
|
$0.0365
59.39%
37.26%
470M
|
Health Technology
WISA
4
|
$9.19
50.66%
33.7%
65M
|
Electronic Technology
EDBL
|
$6.73
47.91%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
640K
|
Manufacturing
TCON
|
$2.33
36.26%
26.61%
2M
|
Health Technology
TIRX
|
$0.48
6.43%
24.58%
4.8M
|
KZIA
|
$0.38
30.58%
23.42%
300K
|
Health Technology
VNDA
|
$5.23
29.14%
22.56%
24M
|
Health Technology
ATNF
|
$1.91
29.05%
22.51%
310K
|
Your saved searches
Save your searches and get alerts when important news are released.